e-Learning in 5 modules: concept, data requirements and the AMNOG process up to the price negotiation
This online event offers a comprehensive overview of marketing authorisation and market access in the Middle East, covering key topics like market entry, intellectual property, lifecycle management, pharmacovigilance and quality considerations, with a focus on Gulf Cooperation Council, Saudi Arabia, the UAE, Jordan and Syria.
Gain a structured, practice-oriented overview of EU HTA, market access and pricing. The seminar covers the evolving EU pharma legislation, the interface between JCA and national HTA and country deep dives: UK & Ireland, Nordics, Germany, France and Italy,
Understand how the Most Favored Nation (MFN) principle is reshaping global pharmaceutical business. This compact online seminar helps you navigate pricing, discount models and market access uncertainty under current and emerging MFN approaches.
This seminar shows pharma teams how to use AI to create evidence-based content and strong cross-channel brand narratives. Through practical frameworks, real use cases and hands-on exercises, participants learn how to scale content efficiently while staying fully compliant. Ideal for marketers who want to apply AI safely and effectively in daily work.
Compact overview of EU requirements for labelling, UDI and product information under the MDR. Learn how legal obligations translate into practical workflows, including UDI allocation and EUDAMED device registration. Ideal for RA, QA and labelling professionals.
Enable teams to plan and run unbranded, non-promotional disease awareness campaigns that inform the public responsibly, remain clearly separate from product promotion, and are ready for EU-wide deployment.
This online conference offers compact expert talks and diverse perspectives on global regulatory strategies, digital transformation and evidence generation. Expect focused insights, practical takeaways and lively discussions with experienced speakers - and stay informed about the latest developments in global regulatory practices.
